Articles

Vanguard Group increases GameStop position, surpassing CEO Ryan Cohen’s stake

The asset-management giant has grown its stake in videogame retailer and original meme stock.

Where crypto ETFs can go next during a second Trump term

A weekly look at the most important news and moves in crypto, and what’s on the horizon in digital assets.

Cisco sees product orders accelerate in the AI era, and its outlook moves higher

Networking company sees a 20% boost in product orders for the latest quarter.

Investment firm stole $658 million in a Ponzi scheme targeting conservatives and immigrants

Using celebrity endorsers like Bill O’Reilly and buying ads targeting conservatives and immigrants, a New Jersey real-estate investment company promised huge returns but stole millions.

Klarna IPO emerges as fintechs gain traction and bankers signal more interest in stock debuts

The buy-now-pay-later company aims to tap into a revival of interest in stocks like Affirm and SoFi.

NFL star Odell Beckham Jr. took his 2021 salary in bitcoin. Here’s how much it’s worth now.

‘Who said taking my salary in bitcoin was dumb?’ he asks now

These teachers, firefighters, and other government workers are missing out on Social Security. This House-passed bill could help.

Millions of public-sector workers are affected by the Windfall Elimination Provision and Government Pension Offset.

Americans’ $1 trillion credit-card debt problem is inching in the right direction as inflation eases

Americans are still building up their credit-card balances, but they’re doing a better job paying those bills on time — and it could be sign that inflation’s bite is easing.

‘I’m young, debt-free and happy-go-lucky’: My boyfriend has $45,000 in debts, two houses, two kids and pays child support. Is he a safe bet to marry?

“Lately, we’ve been discussing the future, including marriage.”

Trump tariffs loom over retail earnings as Home Depot points to ‘industry-wide impact’

Home Depot Inc.’s third-quarter results this week gave a glimpse into the looming issue of tariffs for major U.S. retailers. 

Can my son live in my home permanently after my death? Or will he have to share it with his siblings?

A trust has many options, but you have to make some hard decisions first

This biotech’s stock could double if its treatment for major depressive disorder succeeds, says Mizuho

Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when the company reports data from a late-stage trial of its treatment for major depressive disorder, or MDD, later this year.
1 138 139 140 141 142 1,838